246 related articles for article (PubMed ID: 33067846)
1. Preparation and characterization of curcumin solid dispersion using HPMC.
Yu JY; Kim JA; Joung HJ; Ko JA; Park HJ
J Food Sci; 2020 Nov; 85(11):3866-3873. PubMed ID: 33067846
[TBL] [Abstract][Full Text] [Related]
2. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
3. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
4. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation.
Xiong X; Zhang M; Hou Q; Tang P; Suo Z; Zhu Y; Li H
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110012. PubMed ID: 31546459
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
9. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
[TBL] [Abstract][Full Text] [Related]
10. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
Meng F; Trivino A; Prasad D; Chauhan H
Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
[TBL] [Abstract][Full Text] [Related]
11. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide.
Fathanah A; Setyawan D; Sari R
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837256
[TBL] [Abstract][Full Text] [Related]
12. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of emulsified solid dispersions containing docetaxel.
Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H
Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690
[TBL] [Abstract][Full Text] [Related]
14. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
15. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
Won DH; Kim MS; Lee S; Park JS; Hwang SJ
Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
[TBL] [Abstract][Full Text] [Related]
16. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
17. Formulation strategy of nitrofurantoin: co-crystal or solid dispersion?
Teoh XY; Bt Mahyuddin FN; Ahmad W; Chan SY
Pharm Dev Technol; 2020 Feb; 25(2):245-251. PubMed ID: 31690150
[TBL] [Abstract][Full Text] [Related]
18. The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot-Melt Extrusion-Ⅱ. Optimization of Preparation Process and Evaluation In Vitro and In Vivo.
Fan W; Zhang X; Zhu W; Di L
J Pharm Sci; 2020 Mar; 109(3):1253-1260. PubMed ID: 31794699
[TBL] [Abstract][Full Text] [Related]
19. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
20. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]